GLPwatch
Rybelsus vs Wegovy
Drug comparison
Last updated 2026-05-28 15:46 UTCRybelsus and Wegovy both contain the same active ingredient, semaglutide, and are made by Novo Nordisk. Rybelsus is taken as a daily oral pill to treat type 2 diabetes, while Wegovy is given as a weekly injection to treat obesity and reduce cardiovascular risk.
AI summary of the sources below.
| Rybelsus | Wegovy | |
|---|---|---|
| Active ingredient | semaglutide | semaglutide |
| Manufacturer | novo-nordisk | novo-nordisk |
| Route | oral | subcutaneous injection |
| FDA-approved for | type 2 diabetes | obesity, cardiovascular risk reduction |
| Label updated | 2026-01-30 | 2026-05-05 |